Harnessing Chaperones to Generate Small-Molecule
ization. Rapid changes in the polarity of PIN proteins in response to developmental or environmental cues have been shown to redirect auxin flow and mediate multiple developmental processes (1, 3, 5) , but the mechanism underlying polarity control is largely unresolved. These rapid relocations are enabled by constitutive cycling of PIN proteins. GNOM, an endosomal regulator of vesicle budding that mediates this process, is required for the recycling but does not seem to directly determine the polarity of PIN targeting, because gnom mutants show randomized changes in PIN1 polar localization (15) . In line with this more general function of GNOM in polar auxin transport, most, if not all polar auxin transport-dependent developmental processes are disturbed in gnom mutants (19) . In contrast, the role of PID in controlling PIN polarity is more specific. It appears that PID acts as a binary switch, with subthreshold PID levels leading to basal PIN localization and above-threshold PID levels leading to apical PIN localization. Consistently, the defects observed in both loss-and gain-of-function of PID lines can each be ascribed to a reversion in auxin flow. The observation that auxin controls cellular PID levels (9) raises the intriguing possibility that PID is involved in a feedback mechanism by which auxin influences the polarity of its own flow. Such a regulatory network has been proposed in the classical Bcanalization[ model to explain the selforganizing properties of vascular tissue differentiation (20) and would also account for the dynamic auxin-dependent changes in auxin redistribution underlying phyllotaxis (3, 18) . Even though endogenous PID acts in a limited subset of PIN-dependent development processes, many more cells are competent to respond to PID overexpression. In Arabidopsis, PID belongs to a family of 23 protein kinases, the members of which are differentially expressed. It is therefore likely that ectopic PID expression reveals functions that are normally represented by these different PID family members. Although further experimentation is needed to determine whether PIN proteins are direct targets of PID, it is clear that PID-dependent phosphorylation is an essential intermediate step in the control of polar PIN protein targeting, and thus of directional auxin flow regulating patterning processes. 21 Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid " Aggregation Jason E. Gestwicki, Gerald R. Crabtree, Isabella A. Graef* Protein aggregation is involved in the pathogenesis of neurodegenerative diseases and hence is considered an attractive target for therapeutic intervention. However, protein-protein interactions are exceedingly difficult to inhibit. Small molecules lack sufficient steric bulk to prevent interactions between large peptide surfaces. To yield potent inhibitors of "-amyloid (A") aggregation, we synthesized small molecules that increase their steric bulk by binding to chaperones but also have a moiety available for interaction with A". This strategy yields potent inhibitors of A" aggregation and could lead to therapeutics for Alzheimer's disease and other forms of neurodegeneration.
Aggregation of A$ peptide, generated by proteolytic cleavage of amyloid precursor protein (APP), is a key event in the pathogenesis of Alzheimer_s disease (1) (2) (3) . Genetic studies on Alzheimer_s disease implicate mutations in APP and in genes involved in APP processing (4) in disease development. Because genetic factors that contribute to Alzheimer_s disease also promote A$ aggregation, inhibition of polymerization may have therapeutic benefit. However, this process has proven extremely difficult to prevent (5, 6) . One hurdle to overcome is the poor capacity of low molecular weight drugs to interfere with the protein-protein interactions that generate toxic A$ aggregates. Blocking proteinprotein interactions is a general problem and, despite the importance of these interactions in biologic processes, few inhibitors have been identified (7, 8) . The binding energy that drives protein-protein contacts is typically distributed over a large area and, unlike enzymes, these surfaces lack a defined Bhotspot[ for pharmacological intervention. Additionally, protein surfaces possess a high level of plasticity that can serve to accommodate small molecules, thereby avoiding inhibition.
To approach this problem, we envisioned a Trojan Horse strategy in which a small bifunctional molecule would gain access to the relevant biologic compartment, bind tightly to a chaperone, and thereby gain the steric bulk needed to disrupt a proteinprotein interaction (Fig. 1A) . Chaperones are ideally suited for this approach, as they bind folding or misfolded proteins via exposed hydrophobic surfaces.
In this strategy, one end of the bifunctional molecule binds the FK506 binding protein (FKBP) chaperone family of peptidyl prolyl cis-trans isomerases. FKBPs are encoded by 23 different genes, are highly expressed in all mammalian cells (9, 10) , and are good candidates for recruitment by bifunctional molecules (11) (12) (13) (14) (15) . The other end on September 24, 2007 www.sciencemag.org of the bifunctional molecule is free to interact with aggregating A$. A number of organic compounds, including Congo Red (CR), function as amyloid ligands. These compounds are unsuitable for therapeutic use because high molar ratios of drug to A$ are required to inhibit aggregation (5, 6) . To investigate whether chaperone recruitment could empower these ineffective small molecules with the ability to interfere with A$ aggregation and toxicity, we synthesized SLF-CR (Fig. 1B) (fig. S1 ), which is composed of CR covalently tethered to a synthetic ligand for FKBP (SLF) (16) .
To assess the impact of chaperone recruitment on the potency of aggregation inhibitors, we incubated A$(1-42) in the presence of drug and FKBP. Fibrillogenesis was followed in real time by turbidity measurements. SLF-CR/FKBP (10 6M) completely blocked the formation of A$ aggregates capable of scattering light (Fig. 1C ). Even at nanomolar concentrations, SLF-CR/FKBP Emedian inhibitory concentration (IC 50 ) 0 0.43 6M^delayed amyloid aggregation (Fig. 1D ). Inhibition by SLF-CR required FKBP, but the chaperone alone did not change A$ aggregation. In contrast, CR was a modest inhibitor of turbidity and FKBP did not alter its potency.
As a second measure of inhibition, we explored the aggregation of A$ by the thioflavin T assay. Thioflavin T fluorescence increases in the presence of A$ aggregates, which makes this an attractive assay for screening inhibitors (17) . The IC 50 of SLF-CR/FKBP for decreasing the concentration of thioflavin T-binding species was lower than that of CR/FKBP by a factor of about 5 ( Fig. 1E ). Increasing the molar equivalents of FKBP further enhanced the potency of SLF-CR (Fig. 1F ). In the absence of FKBP, SLF-CR and CR had similar activity. These results suggest that drug-mediated recruitment of FKBP is required for enhanced potency.
Recent evidence has suggested a role for nonfibrillar A$ aggregates in the pathology of Alzheimer_s disease (1-3). Preventing formation of these intermediates is therefore an important measure of inhibitory potency (2, 18) . To explore the ultrastructure of A$ aggregates, we examined drug-treated mixtures by transmission electron microscopy (TEM) and atomic force microscopy (AFM) (19) . At a concentration of 1 6M, CR, SLF-CR, and CR/FKBP were ineffective at reducing the size and abundance of A$ fibrils (Fig. 2, A and B) . However, consistent with the thioflavin T and turbidity experiments, SLF-CR/FKBP almost fully blocked fibril formation. By AFM, smaller, less elongated species were observed in samples treated with SLF-CR/FKBP; these probably represent an intermediate trapped before the formation of fibrils. The particles were approximately uniform in size (28 T 5 nm 2 ; N 0 50), which suggested that SLF-CR/FKBP interrupted fibril formation at a discrete step in the aggregation pathway. Because these species were not observed in samples treated with CR/FKBP, they might represent a qualitative difference between the mechanisms of action of CR and SLF-CR/FKBP. Furthermore, electrophoretic analysis of A$ oligomers showed a predominance of small aggregates in A$ samples treated with SLF-CR/FKBP but not CR/FKBP (fig. S2B) .
Although a strategy that interrupts the aggregation process provides mechanistic insight, the most important criterion of therapeutic potential is the capacity to prevent the formation of neurotoxic aggregates. We examined whether the bifunctional drugs could inhibit neurotoxicity of in vitro aggregated A$. The cell viability of P0 hippocampal neurons was assessed with the 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazoliumbromide (MTT) assay (Fig. 3A) . SLF-CR/FKBP-treated A$ samples were substantially less toxic than untreated or CR/FKBP-treated samples (Fig.  4A) . The EC 50 of SLF-CR/FKBP was lower than that of CR/FKBP by a factor of about 4 (0.9 T 1.3 6M and 4.2 T 1.4 6M, respectively). SLF-CR_s ability to prevent A$-induced neuronal death was dependent on the concentration of FKBP (Fig. 3B) . Thus, drug-mediated recruitment of FKBP not only blocked aggregation but could also inhibit A$ toxicity.
To examine the morphology of the treated neurons, we applied A$ and drug-protein combinations to cultured hippocampal neurons. Cell death was measured by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) assay, and cell morphology was assessed with a cytoskeletal immunostain. As expected, treatment with A$ induced cell death as well as abnormal cell morphology (Fig. 3C ) (fig. S3) ; neurites became dystrophic, some neurons detached from the slides, and those remaining showed signs of nuclear fragmentation and membrane blebbing. Incubation of A$ with FKBP, CR, CR/FKBP, or SLF-CR failed to reduce the number of TUNEL-positive cells or prevent changes in cell morphology. The SLF-CR/FKBP combination, however, markedly blocked toxicity. Moreover, SLF-CR/FKBP-treated neurons displayed mostly normal morphology (Fig.  3C ). These studies show that FKBP recruitment can protect cultured neurons from cell death triggered by toxic A$ aggregates. Our strategy is designed to allow bifunctional drugs to wield the steric bulk of FKBP and prevent A$ from joining the nascent fibril. Improved coverage of the A$ surface might provide superior inhibition, possibly by altering the orientation of FKBP relative to the A$ surface. Our synthetic strategy permits the assembly of bifunctional compounds from a collection of modular targeting domains, recruiting domains, and interchangeable linkers. Therefore, we envisioned that by installing linkers that vary in length and flexibility, we might identify compounds that (Fig. 4A) . In a search for more potent inhibitors, we generated a series of bifunctional compounds that vary in the linker (Fig. 4B) (fig. S3A ). These molecules were named according to the reagent used to create the linker (i.e., the amino acid glycine was used to generate SLF-Gly-CR). When we tested these compounds in conjunction with FKBP in the thioflavin T assay, we found that SLF-But-CR/FKBP and SLF-Benz-CR/FKBP were potent inhibitors (Fig. 4C) (fig. S3B) . The most active compound, SLF-Benz-CR/FKBP, had an IC 50 of about 50 nM, which is lower than that of CR by a factor of 40 and represents an improvement over the parent combination, SLF-CR/FKBP, by a factor of 6. Like SLF-CR, the potency of the compounds was dependent on the availability of FKBP ( fig. S3B ). TEM revealed that the size and shape of A$ intermediates were similar in samples treated with each of the bifunctional molecules (Fig. 4D) . Thus, regardless of the properties of the linker, a common FKBPdrug-A$ complex formed.
To explore the role of the linker in reduction of A$ toxicity, we measured neuronal viability. Consistent with the rank order as measured by thioflavin T fluorescence, SLF-Benz-CR/FKBP and SLF-But-CR/FKBP were, at nanomolar concentrations, significantly more potent than CR/FKBP or SLF-CR/FKBP (Fig. 4E) (fig. S3C ). Even at the high molar concentrations of A$ used in these experiments, SLF-Benz-CR remained active at 100 nM. Despite the modest number of compounds in the linker series, potent inhibitors could be uncovered by assembling modular components.
Our results indicate that recruitment of chaperones can block A$ fibril formation and substantially reduce A$ toxicity. Whereas other inhibitors of A$ aggregation, such as CR and short peptides, are active in the 2 to 10 6M range (5, 6), our best compound was effective at 50 nM. This improvement is likely a result of the inhibitory mechanism used, because the bifunctional molecules were not superior to CR in the absence of chaperone. Analogs based on the SLF-CR model may have potential as therapeutics for Alzheimer_s disease. The advantage of therapeutic intervention at the aggregation step is that it targets a purely pathological event in disease development. Thus, directly inhibiting A$ aggregation with the recruitedchaperone approach might provide a viable complement to recent efforts to reduce the rate of A$ release (20, 21) , enhance its clearance (22, 23) , or template nontoxic aggregates (24) (25) (26) . In animal photoreceptor cells (PRCs), the surface membrane is enlarged for the storage of opsin photopigment (1). Two major types of PRCs are recognized by electron microscopy (table S1). In rhabdomeric PRCs, the apical cell surface folds into microvilli. This is the predominant type of PRC used for vision in invertebrates. In contrast, in vertebrates, the rods and cones of the retina and the PRCs of the pineal eye, a light-sensitive structure in the dorsal diencephalon, are of the ciliary type. In ciliary PRCs, the membrane of the cilium is folded for surface enlargement. To elucidate the evolution of ciliary PRCs, we investigated the photosensitive system in Platynereis dumerilii (Polychaeta, Annelida, Lophotrochozoa) (2, 3) . This species shows ancestral anatomy and development and an ancestral gene inventory (2, 4) . In addition, polychaetes and vertebrates are evolutionarily far apart (2), and thus any feature specifically shared between them as a result of their common evolutionary heritage necessarily existed in Urbilateria, the last common ancestor of all animals with bilateral symmetry.
Platynereis develops different pairs of eyes (5), as demarcated by opsin expression in Fig. 1A : Blarval eyes,[ implicated in larval phototaxis, and Badult eyes,[ active in adult vision. All these eyes use rhabdomeric PRCs. The two pairs of adult eyes originate from a single anlage that is not yet split at the stage of the analysis. To identify ciliary PRCs, we used an antibody directed against acetylated "-tubulin (Fig. 1A) (3) , which specifically labels stabilized microtubules in cilia and axons. In addition to the axonal scaffold, we detected two paired structures in the developing median brain, on the dorsal side of the apical organ (Fig. 1A, arrows) . Electron microscopy (3) revealed that these structures represent multiple cilia (Fig. 1, B to E) that branch out into digits, each inheriting one of the peripheral microtubule doublets (Fig. 1, C and D) . Such ciliated cells have been described for the brain of adult nereidids (6) and other polychaetes (7) and nemertines (8),
